KIMS IPO
KIMS IPO — date, price band, lot size & details 2021
KIMS listed on 28 Jun 2021 at ₹1,009, 22.3% above the ₹825 issue price.
KIMS runs multi-speciality hospitals in Andhra Pradesh and Telangana under the KIMS Hospitals brand. Its total income was Rs 1,340.10 crore in FY2021.
Stock price
KIMS is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 10 November.
- Open 16 Jun 2021
- Close 18 Jun 2021
- Allotment 23 Jun 2021
- Refund/credit 24 Jun 2021
- Listing 28 Jun 2021
Issue summary
The terms of the offer, as filed.
| IPO Dates | 16 to 18 Jun, 2021 |
|---|---|
| Price Band | ₹815 – ₹825 |
| Face Value | ₹10 |
| Lot Size | 18 Shares |
| Issue Size | ₹2143.74 Cr |
| Sale Type | Fresh capital cum OFS |
| Listing On | BSE, NSE |
| Employee Discount | Rs 40.00 per share |
| Registrar | MUFG Intime India Private Limited |
| Min Investment | ₹ 14,850 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 18 shares at the ₹825 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 18 | ₹14,850 |
| Retail (max) | 13 | 234 | ₹1,93,050 |
| S-HNI (min) | 14 | 252 | ₹2,07,900 |
| S-HNI (max) | 67 | 1,206 | ₹9,94,950 |
| B-HNI (min) | 68 | 1,224 | ₹10,09,800 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 6
- 01Total income rose from Rs 923.87 crore in FY2019 to Rs 1,340.10 crore in FY2021.
- 02The company moved from a loss of Rs 48.81 crore in FY2019 to a profit of Rs 205.48 crore in FY2021.
- 03EBITDA rose from Rs 86.82 crore in FY2019 to Rs 381.05 crore in FY2021.
- 04Total borrowing fell from Rs 320.78 crore on 31 March 2020 to Rs 270.47 crore on 31 March 2021.
- 05The pre-issue P/E was 31.16 at the upper band of Rs 825, based on FY2021 EPS of Rs 26.48.
- 06It had 3,064 beds across 9 hospitals on 31 March 2021.
Risks · 5
- 01Rs 1,942.98 crore of the Rs 2,143.74 crore issue was offer for sale, so most of the money went to selling shareholders.
- 02All 9 hospitals are in Andhra Pradesh and Telangana, so results depend on two states.
- 03The company made a loss of Rs 48.81 crore in FY2019, so its profit record is short.
- 04General Atlantic held 38.41% before the issue and sold shares in the offer.
- 05Promoters and the promoter group held only 46.81% before the issue and 38.84% after it.
Three years of numbers
All figures in ₹ crore, as reported in the KIMS offer document.
| Metric | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 1,436.15 | 1,195.89 | 1,119.71 |
| Total Income | 1,340.10 | 1,128.73 | 923.87 |
| Profit After Tax | 205.48 | 115.07 | -48.81 |
| EBITDA | 381.05 | 251.08 | 86.82 |
| NET Worth | 863.73 | 598.13 | 540.66 |
| Reserves and Surplus | 786.14 | 523.64 | 466.17 |
| Total Borrowing | 270.47 | 320.78 | 288.10 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the KIMS RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
KIMS IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Pre-Issue | Post-Issue |
|---|---|---|
| EPS (₹) | ₹26.48 | ₹25.68 |
| P/E Ratio (x) | 31.16 | 32.13 |
| Market Cap at Offer Price (₹ Cr) | ₹6,401.85 | ₹6,601.29 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹825 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
₹191.66 Cr of the issue is earmarked to named objects.
About the company
It offers primary, secondary and tertiary care, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother and child care. Its focus is on tier 2 and tier 3 cities.
On 31 March 2021 it ran 9 multi-speciality hospitals under the KIMS Hospitals brand with 3,064 beds, including over 2,500 operational beds.
The IPO was Rs 2,143.74 crore, with Rs 200.77 crore of fresh issue and Rs 1,942.98 crore of offer for sale by General Atlantic and the promoters. Rs 150.00 crore was planned for repaying borrowings of the company and its subsidiaries.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
KIMS IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Axis Capital
71 issues handledBest listing: Latent View Analytics (+160.0%). Weakest: Shriram Properties (-23.7%).
Kotak Mahindra Capital Company Limited
49 issues handledBest listing: G R Infraprojects (+105.0%). Weakest: Rategain Travel Technologies (-15.3%).
IIFL Capital Services Limited
71 issues handledBest listing: MTAR Technologies (+82.6%). Weakest: Rategain Travel Technologies (-15.3%).
Credit Suisse Securities (India) Pvt. Ltd
6 issues handledBest listing: Zomato (+52.6%). Weakest: Star Health and Allied Insurance Company (-6.1%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of KIMS?
The current Grey Market Premium is ₹0.
What is the KIMS IPO price band?
₹815 to ₹825, on a face value of ₹10.
When is the allotment?
The basis of allotment is 23 June 2021, with listing on 28 June 2021.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
